Optimal times above MICs of ceftibuten and cefaclor in experimental intra-abdominal infections (Q35820708)

10 August 2017

Optimal times above MICs of ceftibuten and cefaclor in experimental intra-abdominal infections (English)

1 reference

10 August 2017

1 reference

C O Onyeji

1

1 reference

10 August 2017

D P Nicolau

series ordinal

2

1 reference

10 August 2017

C H Nightingale

series ordinal

3

1 reference

10 August 2017

R Quintiliani

series ordinal

4

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 May 1994

1 reference

Antimicrobial Agents and Chemotherapy

10 August 2017

1 reference

10 August 2017

38

1 reference

10 August 2017

5

1 reference

10 August 2017

1112-1117

1 reference

The inhibitory quotient. A method for interpreting minimum inhibitory concentration data

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188159

Effect of inoculum size and beta-lactamase production on in vitro activity of new cephalosporins against Haemophilus species

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188159

Comparative antibacterial activity of a new oral cephalosporin, BMY-28100.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188159

In-vitro antimicrobial activity of 7432-S (SCH39720) against commonly isolated respiratory tract pathogens

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188159

Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188159

Comparative in vitro activity of ceftibuten (Sch 39720) against bacterial enteropathogens

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188159

Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188159

Comparison of cefprozil and cefaclor pharmacokinetics and tissue penetration

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188159

Pharmacokinetics and tissue penetration of ceftibuten

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188159

Antibacterial activity of four cephalosporins in an experimental infection in relation to in vitro effect and pharmacokinetics.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188159

Killing and regrowth of bacteria in vitro: a review.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188159

Human pharmacodynamics of beta-lactams, aminoglycosides and their combination

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188159

Impact of the antibiotic dosage schedule on efficacy in experimental lung infections.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188159

Impact of the antibiotic dosage schedule on efficacy in experimental soft tissue infections

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188159

Strategic antibiotic decision-making at the formulary level

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188159

Effect of inoculum and of beta-lactamase on the anti-staphylococcal activity of thirteen penicillins and cephalosporins

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188159

Cefaclor--summary of clinical experience

11 July 2018

1 reference

12 December 2020

Postantibiotic suppression of bacterial growth

1 reference

12 December 2020

Therapeutic efficacy of continuous versus intermittent administration of ceftazidime in an experimental Klebsiella pneumoniae pneumonia in rats

1 reference

12 December 2020

Antibiotic therapy of infections due to Pseudomonas aeruginosa in normal and granulocytopenic mice: comparison of murine and human pharmacokinetics

1 reference

12 December 2020

In vivo postantibiotic effect in a thigh infection in neutropenic mice

1 reference

12 December 2020

Phase I Clinical Studies of 7432-S, a New Oral Cephalosporin: Safety and Pharmacokinetics

1 reference

12 December 2020

Ceftibuten (7432-S, SCH 39720): comparative antimicrobial activity against 4735 clinical isolates, beta-lactamase stability and broth microdilution quality control guidelines

1 reference

12 December 2020

Relevance of the inoculum effect of antibiotics in the outcome of experimental infections caused by Escherichia coli

1 reference

12 December 2020

Simulation of human pharmacokinetic profiles in mice, and impact on antimicrobial efficacy of netilmicin, ticarcillin and ceftazidime in the peritonitis-septicemia model

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.38.5.1112

1 reference

10 August 2017

1 reference

10 August 2017

PubMed publication ID

8067747

1 reference